U.S. Markets closed

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
32.61+0.09 (+0.28%)
At close: 4:02PM EDT
People also watch
Full screen
Previous Close32.52
Bid0.00 x
Ask0.00 x
Day's Range32.30 - 32.81
52 Week Range27.60 - 56.44
Avg. Volume7,554,876
Market Cap33.13B
PE Ratio (TTM)418.08
Earnings DateN/A
Dividend & Yield1.36 (4.38%)
Ex-Dividend Date2017-06-01
1y Target EstN/A
Trade prices are not sourced from all markets
  • Forbes42 minutes ago

    Facebook, Baidu, Coach And 5 Other Blue-Chip Stocks To Buy For Second-Half 2017

    The bull market that kicked off in March 2009 should be on the front cover of AARP magazine. At age 8, it's very old and very overvalued compared to its historical ratios. Given the less than stellar circumstances, how should you invest now?

  • Glaxo's (GSK) Shingles Candidate Phase III Data Positive
    Zacks2 days ago

    Glaxo's (GSK) Shingles Candidate Phase III Data Positive

    GlaxoSmithKline plc (GSK) announced positive top-line results from a phase III revaccination study on its shingles vaccine candidate, Shingrix, in older patients.

  • Reuters3 days ago

    GSK wins $235 million from Teva in Coreg patent trial

    A U.S. jury has ordered Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg, court documents showed. A federal jury in Wilmington, Delaware on Tuesday found that Teva willfully infringed the patent in connection with its sales of a generic version of the drug with a label indicating it could be used for treating chronic heart failure. The jury rejected Teva's contention that the patent was invalid.